Coloplast, a leading company within intimate healthcare, will invest around 100
million euros in a new manufacturing site in Portugal to support the company's
continued growth.
The new manufacturing site will produce Coloplast's intermittent catheters used
by people suffering from urinary retention, such as people with spinal cord
injury or spina bifida, who are unable to empty their bladder. With the new
site, Coloplast aims to meet the increasing global demand for intermittent
catheters, with an emphasis on Europe, which is the company's largest market
accounting for around 60% of its total sales. Despite Europe being a more mature
market, Coloplast continues to see strong demand for its intermittent catheters
with continued growth above the market.
"We have chosen Portugal as the destination for our next manufacturing site for
several reasons. Most importantly, Portugal has qualified and highly trained
labour with an attractive salary level. It is also important that Portugal is in
Europe, where we serve most of our users today and where more and more people
will be needing our products in the years to come. This destination allows us to
diversify our manufacturing footprint in Europe, which is currently concentrated
in Hungary. Finally, the country has a large supply of renewable electricity as
well as an ambition to become carbon neutral by 2050, thereby supporting our
sustainability ambition," says Allan Rasmussen, Executive Vice President of
Global Operations.
Coloplast's long-term organic growth ambition of 8-10% every year requires the
company to establish a new manufacturing site every two to three years to meet
the increasing demand. Coloplast has a global manufacturing network with high
volume production sites in Hungary, China, and Costa Rica, specialised
production in the US, France, Germany, Sweden, and Iceland, as well as an
innovation and pilot plant in Denmark. The new site in Portugal will be 30,000
m2, Coloplast's single largest site to date, and is expected to be operational
as of 2026.
Global Operations Plan 6
The new site in Portugal is part of Coloplast's Global Operations Plan 6 (GOP6)
'Fit for Future'. As previous Global Operations Plans, GOP6 continues to focus
on efficient operations through several different tracks and initiatives. The
aim is to support the company's future growth and profitability development and
enable Coloplast to deliver a long-term EBIT margin of above 30%.
Contacts
Peter Mønster
Sr. Media Relations Manager, Corporate Communications
+45 4911 2623
dkpete@coloplast.com (mailto:dkpete@coloplast.com)
Aleksandra Dimovska
Sr. Director, Investor Relations
+45 4911 2458
dkadim@coloplast.com (mailto:dkadim@coloplast.com)
Â